10x Genomics Inc

Financials

Cash from operating activities 5.18 M-6.75 M34.35 M17.71 M43.21 M40.78 M 136.05 M Cash from investing activities -3.62 M13.67 M1.89 M939 K8.8 M1.8 M 13.44 M Cash from financing activities 156 K4.52 M422 K3.52 M617 K2.24 M 6.8 M Free cash flow 1.29 M-9.46 M32.46 M16.13 M42.53 M39 M 130.12 M

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics Inc

ニュース

Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%

Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?

Priceline, Carvana, DoorDash and more set to report earnings Wednesday

10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript

Canaccord Genuity、10X Genomicsの目標株価を20ドルから22ドルに引き上げ

10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity

Applied Materials and Rivian among market cap stock movers on Friday

Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics

10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates

10Xゲノミクス、新価格戦略の導入に伴い決算試練に直面

10X Genomics faces earnings test as new pricing strategy debuts

Canada stocks higher at close of trade; S&P/TSX Composite up 0.71%